Welcome to the first episode of Phacilitate Talks!

Lindsey Clarke the European Head of Cell and Gene Therapy at bio-techne, Anthony Davies, CEO of Dark Horse Consulting and Cenk Sumen CTO of Stemson Therapeutics dig into how their teams have adjusted to remote work, how covid-19 has impacted clinical trials and what we do as global community to better prepare for the next pandemic.

In this episode I refer to a webinar with Kings College, Sexton Biotechnologies and BioBridge Global which you can sign up for here - https://bit.ly/2WkhOJs

If you’re not already, don’t forget to sign-up as a Phacilitate member, it’s FREE! Every fortnight you’ll get the latest market intelligence, new ideas and exclusive events offers straight to your inbox. Join a community with the same goal; to help advance a new standard in healthcare.

www.phacilitate.co.uk/subscribe